Data supplements
Supplemental Data
Files in this Data Supplement:
Jump to section
Related Articles
Cited By...
- First-in-Human Molecular Imaging of HER2 Expression in Breast Cancer Metastases Using the 111In-ABY-025 Affibody Molecule
- Three Methods for 18F Labeling of the HER2-Binding Affibody Molecule ZHER2:2891 Including Preclinical Assessment
- Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics
- 18F-Fluorobenzoate-Labeled Cystine Knot Peptides for PET Imaging of Integrin {alpha}v{beta}6
- Optical Imaging with Her2-Targeted Affibody Molecules Can Monitor Hsp90 Treatment Response in a Breast Cancer Xenograft Mouse Model
- Proof-of-Concept Study of Monitoring Cancer Drug Therapy with Cerenkov Luminescence Imaging
- Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions
- Molecular Design and Optimization of 99mTc-Labeled Recombinant Affibody Molecules Improves Their Biodistribution and Imaging Properties
- Towards detecting the HER-2 receptor and metabolic changes induced by HER-2-targeted therapies using medical imaging
- A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression
- Changes in HER2 Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and 18F-Labeled Affibody Molecules
- On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
- Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography